Licensed Practical Nurse in Galloway, NJ Accepting Medicare

5 Licensed Practical Nurse nurses found. Showing 1 - 5

Margretta Broome, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 169 S Thoreau Ter, Galloway, NJ 08205 Phone: 800-950-6066

Daniel L Kaufman, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 54 W Jimmie Leeds Rd, Suite 8, Galloway, NJ 08205 Phone: 609-404-7300    Fax: 609-404-7301

Michael Caruso, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 421 Dennis Dr, Galloway, NJ 08205 Phone: 609-652-3691    Fax: 609-652-3691

Olivia Tarver, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 418 Spencer Ln, Galloway, NJ 08205 Phone: 800-950-6066

Marie Lucien, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 153 Kensington Dr, Galloway, NJ 08205 Phone: 800-950-6066

News Archive

California hospital error data reveals fines, gaps in reporting

"California regulators have fined hospitals just over $1 million for failing to report incidents such as leaving a foreign object in a patient after a surgery or operating on the wrong person, according to data released to California Watch by the California Department of Public Health."

New study further validates use of vaginal progesterone to decrease risk of preterm birth

A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.

Genomic expansion and diversification in a African sleeping sickness parasite allow it to evade host detection

A team of scientists headed by Dr. Sara Melville at the University of Cambridge has shown that the parasite known to cause African sleeping sickness has evolved an unusual chromosomal structure as a result of environmental adaptation.

Read more Medical News

› Verified 8 days ago